Financial reports
20-F
2023 FY
Annual report (foreign)
15 Apr 24
20-F
2022 FY
Annual report (foreign)
1 May 23
20-F
2021 FY
Annual report (foreign)
2 May 22
20-F/A
2020 FY
Annual report (foreign) (amended)
30 Mar 21
20-F
2020 FY
Annual report (foreign)
29 Mar 21
20-F
2019 FY
Annual report (foreign)
30 Apr 20
20-F
2018 FY
Annual report (foreign)
29 Apr 19
20-F
2017 FY
Annual report (foreign)
27 Apr 18
20-F
2016 FY
Annual report (foreign)
7 Apr 17
20-F
2015 FY
Annual report (foreign)
11 Apr 16
Current reports
6-K
Current report (foreign)
23 Apr 24
6-K
The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic
26 Mar 24
6-K
The9 Signed a Legally Binding Term Sheet to Acquire a Leading AIGC Driven Digital Human SaaS Platform ShenMa
5 Mar 24
6-K
Current report (foreign)
21 Feb 24
6-K
The9’s Chairman and CEO to Purchase No More Than 10% of The9 ADSs in the Open Market
19 Jan 24
6-K
Current report (foreign)
17 Jan 24
6-K
Current report (foreign)
17 Jan 24
6-K
Current report (foreign)
29 Dec 23
6-K
The9 Limited Raised US$12 million in a Private Placement Transaction to Fund Business Growth
30 Nov 23
6-K
Current report (foreign)
17 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
2 May 23
424B5
Prospectus supplement for primary offering
24 Nov 21
424B5
Prospectus supplement for primary offering
18 Nov 21
S-8
Registration of securities for employees
27 Aug 21
424B5
Prospectus supplement for primary offering
7 Jun 21
424B5
Prospectus supplement for primary offering
4 May 21
424B5
Prospectus supplement for primary offering
3 May 21
POS AM
Prospectus update (post-effective amendment)
7 Apr 21
424B5
Prospectus supplement for primary offering
5 Apr 21
F-3ASR
Automatic shelf registration (foreign)
30 Mar 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
15 Apr 21
CORRESP
Correspondence with SEC
23 Mar 21
UPLOAD
Letter from SEC
24 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
UPLOAD
Letter from SEC
25 Jan 21
EFFECT
Notice of effectiveness
30 Sep 20
CORRESP
Correspondence with SEC
25 Sep 20
CORRESP
Correspondence with SEC
25 Sep 20
UPLOAD
Letter from SEC
10 Aug 20
CORRESP
Correspondence with SEC
4 Aug 20
Ownership
SC 13D/A
Zhu Jun
30 Jan 24
SC 13D/A
Zhu Jun
27 Sep 23
SC 13G/A
CVI Investments, Inc.
14 Feb 22
SC 13G/A
Kong Jianping
14 Feb 22
SC 13G
Kong Jianping
17 Nov 21
SC 13D/A
Zhu Jun
17 Sep 21
SC 13D/A
Zhu Jun
15 Apr 21
SC 13G
CVI Investments, Inc.
12 Apr 21
SC 13G/A
Ark Pacific Capital Management Ltd
13 Jan 21
SC 13G
Ark Pacific Capital Management Ltd
10 Jul 20